Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
For most reconstitutions, a 1 mL or 3 mL insulin or luer-lock syringe with a 21G to 25G needle works well
Only qualified and licensed professionals should handle these products
The molecule was developed by the Australian pharmaceutical company Metabolic Pharmaceuticals (in collaboration with Monash University) and advanced through Phase I safety trials and a Phase IIb obesity efficacy trial enrolling approximately 900 participants in total
Not intended for human or veterinary use, clinical use, diagnostic use, food, drug, cosmetic or dietary-supplement use
Recommended Products Comparison Table Comparison Table BPC-157 Overview BPC-157 Overview Mechanisms: Stimulates angiogenesis, balances nitric oxide, and modulates inflammation to protect and regenerate tissues Learn More Primary Uses: Tendon/ligament repair, muscle regeneration, gut lining protection, neuroprotection, organ support Learn More Administration: Oral (acid-stable) Subcutaneous or intramuscular injection Safety Highlights: No mortality or organ toxicity in high-dose animal studies
